OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)
Titel:
OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)
Auteur:
Fleseriu, M. Gadelha, M. Bronstein, M.D. Brue, T. Coculescu, M. Guitelman, M. Pronin, V. Raverot, G. Shimon, I. Fleck, J. Aout, M. Pedroncelli, A.M. Colao, A.